Myocardial Infarction News and Research

RSS

Patient and family satisfaction with acute care transfers for STEMI patients can be high, survey reveals

The Minneapolis Heart Institute Foundation today announced the results of survey research aimed at discovering patient and family satisfaction with acute care transfers for patients with STEMI (ST-segment elevation myocardial infarction), a severe heart attack best treated quickly with specialized care.

6 Mar 2014

Outbursts of anger may trigger heart attacks and strokes, shows study

Outbursts of anger may trigger heart attacks, strokes and other cardiovascular problems in the two hours immediately afterwards, according to the first study to systematically evaluate previous research into the link between the extreme emotion and all cardiovascular outcomes.

4 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.

25 Feb 2014

High BP medications may increase risk of falls and fall injuries in older patients

Medication to treat high blood pressure (BP) in older patients appears to be associated with an increased risk for serious injury from falling such as a hip fracture or head injury, especially in older patients who have been injured in previous falls.

25 Feb 2014

New class of drugs developed to treat cancer, reduces sudden cardiac death risk after heart attack

A researcher at the Cardiovascular Institute (CVI) at Rhode Island, The Miriam and Newport hospitals has found that a new class of drugs, originally developed to treat cancer, reduces sudden cardiac death risk after a heart attack. The findings were published online in advance of print in the Journal of the American College of Cardiology.

25 Feb 2014

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

After a heart attack, there is often permanent damage to a portion of the heart. This happens, in part, because cardiac muscle cells are terminally differentiated and cannot proliferate after blood flow is blocked off to the heart.

20 Feb 2014

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.

20 Feb 2014

Discovery could lead to improved early detection, prevention strategies for sudden cardiac death

UC Irvine researchers have found a specific genetic flaw that is connected to sudden death due to heart arrhythmia - a leading cause of mortality for adults around the world.

18 Feb 2014

Blood pressure effects unclear in long-term stroke survivors

Long-term survivors of stroke whose blood pressure is at target levels have worse outcomes than those with slightly elevated levels, research suggests.

17 Feb 2014

NCKU research team identifies medicine capable of rejuvenating aged hearts

A southern Taiwan-based National Cheng Kung University (NCKU) research team has identified the critical time period and a drug as treatment for cardiac repairing, the university revealed recently at a press conference.

14 Feb 2014

Study: Metabolic risk factors cluster similarly in children and adults

Metabolic risk factors cluster similarly in children and adults, according to a study carried out at the University of Eastern Finland. Furthermore, in adults, the clustering of these risk factors increases the risk of premature death caused by type 2 diabetes, myocardial infarction and cardiovascular diseases.

13 Feb 2014

New study analyses risk factors and mortality among heroin, cocaine consumers admitted to treatment

A new study analyses the risk factors and excess mortality among heroin and cocaine consumers admitted to treatment in Spain. The results reveal that the fatality rate among consumers of both drugs is 14.3 times higher than for the general population, while among those only using cocaine, it is 5.1 times higher.

10 Feb 2014

Study examines risks and benefits of testosterone therapy for older men

According to a statement issued today by the Endocrine Society, the risks and benefits of testosterone therapy for older men with declining levels of the hormone need to be fully evaluated.

10 Feb 2014

Whole diet approach has more evidence for reducing cardiovascular risk

A study published in The American Journal of Medicine reveals that a whole diet approach, which focuses on increased intake of fruits, vegetables, nuts, and fish, has more evidence for reducing cardiovascular risk than strategies that focus exclusively on reduced dietary fat.

6 Feb 2014

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease.

5 Feb 2014

Prediction models can be useful for heart team to determine best treatment strategy

Detailed prediction models that project long-term patient mortality following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) surgery can be useful for the heart team when determining the best treatment strategy for individual patients, according to a study in the February 2014 issue of The Annals of Thoracic Surgery.

31 Jan 2014

Myocardial Infarction News and Research

Patient and family satisfaction with acute care transfers for STEMI patients can be high, survey reveals

Outbursts of anger may trigger heart attacks and strokes, shows study

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

FDA approves Iroko Pharmaceuticals’ TIVORBEX capsules

High BP medications may increase risk of falls and fall injuries in older patients

New class of drugs developed to treat cancer, reduces sudden cardiac death risk after heart attack

Study finds Cyclin A2 protein induces cardiac regeneration after myocardial infarction

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

Discovery could lead to improved early detection, prevention strategies for sudden cardiac death

Blood pressure effects unclear in long-term stroke survivors

NCKU research team identifies medicine capable of rejuvenating aged hearts

Study: Metabolic risk factors cluster similarly in children and adults

New study analyses risk factors and mortality among heroin, cocaine consumers admitted to treatment

Study examines risks and benefits of testosterone therapy for older men

Whole diet approach has more evidence for reducing cardiovascular risk

Scientists engineered microchip coated with blood vessel cells to study cardiovascular nanomedicine

Prediction models can be useful for heart team to determine best treatment strategy

Checklists and feedback for ambulance crews improve care for heart attack and stroke patients

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

Research roundup: Patient safety measure results 'disappointing'

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News